NCR Plus new quarantine status may be out on Friday—Palace

Published May 11, 2021, 4:36 PM

by Raymund Antonio

Malacañang said on Tuesday the new quarantine classifications imposed on Metro Manila and four nearby provinces in the NCR Plus Bubble will be announced on May 14, the last day of the modified enhanced community quarantine (MECQ).


MECQ is the second strictest quarantine level that is in effect in Metro Manila, Cavite, Bulacan, Rizal, and Laguna provinces.

Presidential spokesperson Harry Roque noted the Inter-agency Task Force (IATF) on COVID-19 will meet on Friday so they can make the quarantine recommendations to President Duterte on the same day.

The Chief Executive will then decide whether or not the MECQ would be extended in the NCR Bubble until the rest of May.

“Inaasahan po natin na itatawag na lang po natin kay Presidente ang rekomendasyon at magdedesisyon ang Presidente kung approved siya o hindi (We expect that we will just inform the President over the phone about the recommendation and he will decide whether it’s approved or not),” Roque said in his virtual presser.

“Ang anunsiyo po sa bagong quarantine classification, most likely sa darating na pong Biyernes (The announcement of new quarantine classification will be mostly likely on Friday),” he added.

The NCR Plus region has been under restrictive quarantine classification since Holy Week last month due to the surge in coronavirus disease (COVID-19) cases.

In the same briefing, the Palace official said it has yet to be determined whether there is community transmission of the Indian COVID-19 variant B.1.617 in the country to warrant the extension of the MECQ


“Let’s just say that despite doing our best to stop the entry of this variant, we are still not sure that there is community transmission because we have been very careful,” Roque said in Filipino.

The Department of Health (DOH) confirmed that there are two cases of India’s double-mutant variant in the Philippines. The variant is called as such because it contains two famous mutations—the L452R and E484Q that could help the virus evade an immune response.